BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6663595)

  • 1. Effects of serum from patients with system lupus erythematosus on leukocyte cytotoxicity: modulation of NK activity and ADCC.
    Ytterberg SR; Huard TK; Schnitzer TJ
    J Rheumatol; 1983 Dec; 10(6):906-12. PubMed ID: 6663595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
    Kozlowski SH; Hirsen DJ; Jackson EJ
    J Rheumatol; 1982; 9(1):59-62. PubMed ID: 7086780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
    Miller ML; Lantner R; Pachman LM
    J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
    Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
    J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors.
    Zippel D; Lackovic V; Kocisková D; Rovenský J; Borecký L; Stelzner A
    Acta Virol; 1989 Sep; 33(5):447-53. PubMed ID: 2483602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
    Kumagai S; Steinberg AD; Green I
    J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus.
    Yabuhara A; Yang FC; Nakazawa T; Iwasaki Y; Mori T; Koike K; Kawai H; Komiyama A
    J Rheumatol; 1996 Jan; 23(1):171-7. PubMed ID: 8838528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
    Ewan PW; Barrett HM; Pusey CD
    J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity.
    Nelson DL; Poplack DG; Holiman BJ; Henkart PA
    Clin Exp Immunol; 1979 Mar; 35(3):447-53. PubMed ID: 455783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
    Jewett A; Giorgi JV; Bonavida B
    J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.
    Park YW; Kee SJ; Cho YN; Lee EH; Lee HY; Kim EM; Shin MH; Park JJ; Kim TJ; Lee SS; Yoo DH; Kang HS
    Arthritis Rheum; 2009 Jun; 60(6):1753-63. PubMed ID: 19479851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.
    Sharland A; Lee JH; Saidman S; Waneck GL
    Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer activity of human lymphocytes against colon cancer cells.
    Helms RA; Bull DM
    Gastroenterology; 1980 Apr; 78(4):738-44. PubMed ID: 7353760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults.
    Jenkins M; Mills J; Kohl S
    Pediatr Res; 1993 May; 33(5):469-74. PubMed ID: 8511019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon and natural killer cells in systemic lupus erythematosus.
    Strannegård O; Hermodsson S; Westberg G
    Clin Exp Immunol; 1982 Nov; 50(2):246-52. PubMed ID: 6185256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.